The global forage analysis market was valued at USD 494.4 million in 2017; this is projected to grow at a CAGR of 5.1% from 2018, to reach USD 661.1 million by 2023. The objectives of the report are to define, segment, and estimate the size of the global market. Furthermore, the market has been segmented on the basis of forage type, target, livestock, method, and region. The report also aims to provide detailed information about the crucial factors influencing the growth of the market, strategical analysis of the micro markets, opportunities for stakeholders, details of the competitive landscape, and the profiles of the key players with respect to their market share and competencies.
The key players in the forage analysis market include SGS (Switzerland), Eurofins Scientific (Luxembourg), Intertek (UK), Cargill (US), CVAS (US), RJ Hill Laboratories (New Zealand), Dodson & Horrell (UK), Cawood Scientific (England), Servi-Tech (US), DairyLand Laboratories (US), Dairy One (US), Minnesota Valley Testing Laboratories (US), and Massey Feeds (UK). These key players focus on various business strategies such as acquisitions and agreements & expansions to improve their market presence and product portfolio. SGS and Eurofins Scientific are the top two companies in the forage analysis market, based on their product offerings and geographic presence.
Make an Inquiry:
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=71711773
SGS is involved in inspection, verification, testing, certification, and quality assurance services. Globally, the company operates through a network of more than 2,400 offices and laboratories across Europe, the Middle East, the Americas, Africa, and Asia Pacific. The company offers its services across nine major industries through its nine business lines including consumer & retail; agriculture food & life ; oil, gas & chemical; minerals; industrial; government & institution; transportation; certification & business enhancement; and environmental health & safety. It offers forage analysis under its agriculture and food segment. The company majorly focuses on expansion as its growth strategy. For instance, in June 2018, the company expanded its analytical capacities in São Paulo, Brazil, offered under good laboratory practice (GLP).
Eurofins Scientific is an international group of laboratories that provide testing and support services to pharmaceutical, food, environmental, agricultural, and consumer product industries as well as governments. Globally, the company operates through 400 laboratories in 44 countries. The company has a strong footprint in Europe, North America, and South America, with a growing presence in the Asia Pacific region. The company operates through its major divisions, which include food & feed testing, biopharma services, agroscience services, agro testing, clinical diagnostics, cosmetics testing, consumer product testing, forensic services, environmental testing, genomic services, medical devices, Eurofins technologies, and REACH services. It offers forage analysis under its food & feed testing division. The company focuses on acquisitions and expansions as its growth strategy. In January 2018, the company acquired Craft Technologies, Inc. (US), which provides analysis of nutrients, vitamins, carotenoids, bioflavonoids, and phytochemicals. With this acquisition, the company is looking forward to expanding its offerings in food & feed and forage testing in the global market.
Forage Analysis Market to See Major Growth by 2023
Market HighlightsThe North America clinical laboratory test market has been evaluated as rapidly growing market and expected that the market will reach high growth figures.
Other factors such as increasing prevalence of disease, growth of outpatient services, government funds new payment and service delivery model and expansion of hospital outreach services are the adding to the market growth of clinical laboratory market in North America.
Government rules and regulations cheaper services in government owned hospitals and increasing interest rates are some of the factors acting as restraints for the global clinical laboratory test market.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/2249Certainly, both the companies offer a wide range of diagnostic testing services, right from routine CBC testing to prenatal tests, and further to highly sensitive cancer and genetics tests.
LabCorp follows Quest and accounting for second largest market share of the domestic market but is growing at a faster pace than its main rival.
In addition to this, Spectra (U.S.), Renalab Inc. (U.S.), Berkeley Heart Lab (U.S.), and others together contributes more than 60% of the market share of total market.North America clinical laboratory test market Players:The key players are AURORA Diagnostic (USA), Laboratory Corporation of America (US), LifeLabs Medical Laboratories (Canada), and Quest Diagnostics (US).Segmentation:The North America clinical laboratory test market is majorly segmented on the basis of type of laboratory, type of test, and by country.
Based on the type of laboratory, the market is segmented into hospital-based laboratory, central/ independent laboratory, physician office laboratory, and others.
The report analyzes the market by product & service, type of medical device, application, and region.
On the basis of product & service, the reprocessing support and services segment accounted for the largest share in 2016, owing to the increased adoption of third-party reprocessing services over in-house reprocessing services by hospitals, clinics, surgical centers, clinical pathologies, and other healthcare organizations.The major factors that are expected to be driving the genotyping assay market are technological advancements and the decreasing prices of DNA sequencing.
The increasing incidence of genetic diseases and rising awareness of personalized medicine, growing importance of genotyping in drug development, and the increasing demand for bioinformatics solutions in data analysis are also expected to promote market growth in the coming years.
The objective of the report is to define, describe, and forecast the genotyping assay market size based on product & service, technology, application, end user, and region.MarketsandMarkets forecasts the Genotyping Assay market to grow from USD 11.8 billion in 2018 to USD 31.9 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 22.0% during the forecast period.Market Dynamics1.
Low Prices of Reprocessed Medical Devices2.
Pressure to Reduce Volume of Regulated Medical WasteThe sequencing segment is expected to witness a faster growth rate in this market due to factors such as, the increasing application areas of DNA sequencing technologies, technological advancements, the availability of high-speed sequencing instruments, and the growing uptake of the hybrid approach of sequencing.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595The pharmaceutical and biopharmaceutical companies segment is expected to witness the highest growth during the forecast period.
The report "Reaction Monitoring Market by Technology (Spectroscopy (MS, IR, UV, NMR, Raman), Chromatography (GC, LC), Calorimetry, Titrimetry, XRD), Mode (Quantitative, Qualitative), End User (Research, Pharma-Biotech, Food & Beverages Co) - Global Forecasts to 2022", The global reaction monitoring market is projected to reach USD 1.52 Billion by 2022 from USD 1.15 Billion in 2017, at a CAGR of 5.7%.Factors such as stringent regulatory guidelines in the pharmaceutical & biotechnology industry; expansion of the food and beverages industry; and Increasing public-private investments in life science research are driving the reaction monitoring market.However, high product costs associated with analytical instruments is the major factor restraining the market growth to a certain extent.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52531136Based on technology, the spectroscopy segment is estimated to account for the largest segment of the market in 2017On the basis of technology, the multiple reaction monitoring market is segmented into spectroscopy, chromatography, X-ray diffraction, calorimetry, and titrimetry.
The spectroscopy segment is expected to account for largest share of the reaction monitoing market in 2017.
The large share of this segment can be attributed to the widespread use of spectroscopic techniques, increasing drug development pipelines, and stringent regulatory compliance for drug manufacturing & food processing protocols.Based on end user, the pharmaceutical, biopharmaceutical, and biotechnology companies segment expected to account for the largest share of the MRM 0market in 2017 Based on end user, the reaction monitoring market is segmented into pharmaceutical, biopharmaceutical, and biotechnology companies, life science and genomic research facilities, food and beverage industry, pollution monitoring and control industry, and other end users.
The pharmaceutical, biopharmaceutical, and biotechnology companies segment is estimated to command the largest share of the global multiple reaction monitoring market in 2017.In 2017, North America is expected to account for the largest share of the reaction monitoring technology market Geographically, the reaction monitoring technology market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America is expected to account for the largest share of the global reaction monitoring market in 2017.
The growth of this region is attributed to the availability of private-public funding & investments for life science research, stringent regulatory framework for drug development & commercialization, effective implementation & industrial compliance with food safety regulations, rising adoption of technologically advanced pollution monitoring & control products, and growing number of clinical researches in this region.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=52531136Key PlayersAgilent (US), Danaher (US), PerkinElmer (US), Shimadzu (Japan), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Bruker (US), Waters (US), Hitachi High-Technologies (Japan), Merck (Germany), ABB (Switzerland), Mettler-Toledo International (US) , and HORIBA (Japan).
The rising demand for various international cuisines that includes authentic dishes from all around the world is boosting the global Hot Sauce Market, says Fortune Business Insights in their new report.
The report is titled,”Hot Sauce Market Size, Share and Industry Analysis By Type (Tabasco Sauce, Habanero Sauce, Jalapeño Sauce, Sweet and Spicy Sauce), By Distribution Channel (Mass Merchandisers, Specialist Retailers, Convenience Stores, Online Retail), and Regional Forecast 2019 - 2026” and it has prognosticated to grow remarkably with rising demand for spicy, bold, and exotic international cuisines among consumers.The report provides an elaborative analysis of the market dynamics and competitive landscape.
The forecast period is set from 2019 to 2026 and the market is expected to grow at 6.5% CAGR.Rise in Demand for Meat-based Food Items to Augment GrowthIncreasing population and the need to feed the growing population with diversified food products are key factors boosting the global Hot Sauce Market.
Such factors contribute to the growth of the global market for hot sauce.Additionally, the rising popularity of various Asian cuisines, which includes spicy, tangy, and unique taste such as Thai, Chinese, and Indian food items, is also propelling the Hot Sauce Market growth.
Besides this, there is a rising demand for exotic cuisines and fast-food, which is fueling the demand for hot sauce globally.List of Best Companies Covered in the report Hot Sauce Market:Kraft Heinz Co.McCormick & Co Inc.Campbell Soup Co.The Unilever GroupThe Clorox CompanyPinnacle Foods, Inc.Conagra Brands, Inc.McIlhenny CompanyThe French's Food Company LLCHormel Foods CorporationHowever, the rising price of ingredients used for making sauce such as high price of spices, condiments, seasonings, and others is anticipated to cause hindrance to the growth of the market globally.
Nevertheless, the growth of hospitality and tourism sector on a global basis has further helped to intensify various international cuisines.
Growing geriatric population and increasing molecular, pathological, and immunological tests are expected to bolster market growthClinical Laboratory Tests Market Size – USD 189.8 billion in 2020, Market Growth – at a CAGR of 7.3%, Market Trends – Surging prevalence of target diseases such as tuberculosis, diabetes, etc.The Global Clinical Laboratory Tests Market size is expected to reach USD 327.4 billion by 2028 at a CAGR of 7.3%, according to the latest report by Reports and Data.
In addition, rising prevalence of target diseases, such as tuberculosis and diabetes, and cardiovascular disorders, growing awareness about regular body profiling, and increasing demand for molecular, pathological, and immunological testing are expected to further stimulate revenue growth.
Strict government norms regarding clinical laboratory testing create further opportunities for the growth of the global clinical laboratory tests market.Clinical laboratory tests refer to various medical tests performed in a laboratory to gain information about the health condition of a patient by using their blood or urine samples.
Principal areas of clinical laboratory testing include clinical microbiology, clinical chemistry, hematology, DNA testing, and reproductive biology tests.
Some of the commonly used clinical laboratory tests are Complete Blood Count (CBC), comprehensive metabolic panel, basic metabolic panel, liver panel, lipid panel, HbA1c, HGB/HCT, urinalysis, and thyroid stimulating hormone.
This segment’s growth is primarily attributed to rising prevalence of lifestyle-induced diseases such as cardiovascular disorders and growing health awareness among people globally.Based on stand-alone laboratories, the service provider segment is expected to record fastest revenue growth rate of nearly 4.7% over the forecast period.
The report analyzes the market by product & service, type of medical device, application, and region.
On the basis of product & service, the reprocessing support and services segment accounted for the largest share in 2016, owing to the increased adoption of third-party reprocessing services over in-house reprocessing services by hospitals, clinics, surgical centers, clinical pathologies, and other healthcare organizations.The major factors that are expected to be driving the genotyping assay market are technological advancements and the decreasing prices of DNA sequencing.
The increasing incidence of genetic diseases and rising awareness of personalized medicine, growing importance of genotyping in drug development, and the increasing demand for bioinformatics solutions in data analysis are also expected to promote market growth in the coming years.
The objective of the report is to define, describe, and forecast the genotyping assay market size based on product & service, technology, application, end user, and region.MarketsandMarkets forecasts the Genotyping Assay market to grow from USD 11.8 billion in 2018 to USD 31.9 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 22.0% during the forecast period.Market Dynamics1.
Low Prices of Reprocessed Medical Devices2.
Pressure to Reduce Volume of Regulated Medical WasteThe sequencing segment is expected to witness a faster growth rate in this market due to factors such as, the increasing application areas of DNA sequencing technologies, technological advancements, the availability of high-speed sequencing instruments, and the growing uptake of the hybrid approach of sequencing.Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595The pharmaceutical and biopharmaceutical companies segment is expected to witness the highest growth during the forecast period.
According to the latest research report published by Dhirtek Business Research, the global clinical microbiology market report provides detailed information on the factors driving the growth of the clinical microbiology market.
This pandemic is having an impact on various sectors of the economy.
It predicts that the global economy will suffer as a result of the loss of trillions of dollars.
To compete in a competitive market, the companies must identify product opportunities based on their strengths.
This study provides a platform for understanding the various exciting and rising prospects in the field of clinical microbiology, and it will help every producer, distributor, or even user understand and succeed in this burgeoning industry.
Obtain a Sample Report and the Table of Content for the Clinical Microbiology Market Report:https://www.dhirtekbusinessresearch.com/market-report/Clinical-Microbiology-Market/request-for-sample-report Study Goals and Objectives of Global Clinical Microbiology Market The report provides information on the market impact of clinical microbiology.
The rising demand for various international cuisines that includes authentic dishes from all around the world is boosting the global Hot Sauce Market, says Fortune Business Insights in their new report.
The report is titled,”Hot Sauce Market Size, Share and Industry Analysis By Type (Tabasco Sauce, Habanero Sauce, Jalapeño Sauce, Sweet and Spicy Sauce), By Distribution Channel (Mass Merchandisers, Specialist Retailers, Convenience Stores, Online Retail), and Regional Forecast 2019 - 2026” and it has prognosticated to grow remarkably with rising demand for spicy, bold, and exotic international cuisines among consumers.The report provides an elaborative analysis of the market dynamics and competitive landscape.
The forecast period is set from 2019 to 2026 and the market is expected to grow at 6.5% CAGR.Rise in Demand for Meat-based Food Items to Augment GrowthIncreasing population and the need to feed the growing population with diversified food products are key factors boosting the global Hot Sauce Market.
Such factors contribute to the growth of the global market for hot sauce.Additionally, the rising popularity of various Asian cuisines, which includes spicy, tangy, and unique taste such as Thai, Chinese, and Indian food items, is also propelling the Hot Sauce Market growth.
Besides this, there is a rising demand for exotic cuisines and fast-food, which is fueling the demand for hot sauce globally.List of Best Companies Covered in the report Hot Sauce Market:Kraft Heinz Co.McCormick & Co Inc.Campbell Soup Co.The Unilever GroupThe Clorox CompanyPinnacle Foods, Inc.Conagra Brands, Inc.McIlhenny CompanyThe French's Food Company LLCHormel Foods CorporationHowever, the rising price of ingredients used for making sauce such as high price of spices, condiments, seasonings, and others is anticipated to cause hindrance to the growth of the market globally.
Nevertheless, the growth of hospitality and tourism sector on a global basis has further helped to intensify various international cuisines.
Market HighlightsThe North America clinical laboratory test market has been evaluated as rapidly growing market and expected that the market will reach high growth figures.
Other factors such as increasing prevalence of disease, growth of outpatient services, government funds new payment and service delivery model and expansion of hospital outreach services are the adding to the market growth of clinical laboratory market in North America.
Government rules and regulations cheaper services in government owned hospitals and increasing interest rates are some of the factors acting as restraints for the global clinical laboratory test market.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/2249Certainly, both the companies offer a wide range of diagnostic testing services, right from routine CBC testing to prenatal tests, and further to highly sensitive cancer and genetics tests.
LabCorp follows Quest and accounting for second largest market share of the domestic market but is growing at a faster pace than its main rival.
In addition to this, Spectra (U.S.), Renalab Inc. (U.S.), Berkeley Heart Lab (U.S.), and others together contributes more than 60% of the market share of total market.North America clinical laboratory test market Players:The key players are AURORA Diagnostic (USA), Laboratory Corporation of America (US), LifeLabs Medical Laboratories (Canada), and Quest Diagnostics (US).Segmentation:The North America clinical laboratory test market is majorly segmented on the basis of type of laboratory, type of test, and by country.
Based on the type of laboratory, the market is segmented into hospital-based laboratory, central/ independent laboratory, physician office laboratory, and others.
Growing geriatric population and increasing molecular, pathological, and immunological tests are expected to bolster market growthClinical Laboratory Tests Market Size – USD 189.8 billion in 2020, Market Growth – at a CAGR of 7.3%, Market Trends – Surging prevalence of target diseases such as tuberculosis, diabetes, etc.The Global Clinical Laboratory Tests Market size is expected to reach USD 327.4 billion by 2028 at a CAGR of 7.3%, according to the latest report by Reports and Data.
In addition, rising prevalence of target diseases, such as tuberculosis and diabetes, and cardiovascular disorders, growing awareness about regular body profiling, and increasing demand for molecular, pathological, and immunological testing are expected to further stimulate revenue growth.
Strict government norms regarding clinical laboratory testing create further opportunities for the growth of the global clinical laboratory tests market.Clinical laboratory tests refer to various medical tests performed in a laboratory to gain information about the health condition of a patient by using their blood or urine samples.
Principal areas of clinical laboratory testing include clinical microbiology, clinical chemistry, hematology, DNA testing, and reproductive biology tests.
Some of the commonly used clinical laboratory tests are Complete Blood Count (CBC), comprehensive metabolic panel, basic metabolic panel, liver panel, lipid panel, HbA1c, HGB/HCT, urinalysis, and thyroid stimulating hormone.
This segment’s growth is primarily attributed to rising prevalence of lifestyle-induced diseases such as cardiovascular disorders and growing health awareness among people globally.Based on stand-alone laboratories, the service provider segment is expected to record fastest revenue growth rate of nearly 4.7% over the forecast period.
The report analyzes the market by product & service, type of medical device, application, and region.
On the basis of product & service, the reprocessing support and services segment accounted for the largest share in 2016, owing to the increased adoption of third-party reprocessing services over in-house reprocessing services by hospitals, clinics, surgical centers, clinical pathologies, and other healthcare organizations.The major factors that are expected to be driving the genotyping assay market are technological advancements and the decreasing prices of DNA sequencing.
The increasing incidence of genetic diseases and rising awareness of personalized medicine, growing importance of genotyping in drug development, and the increasing demand for bioinformatics solutions in data analysis are also expected to promote market growth in the coming years.
The objective of the report is to define, describe, and forecast the genotyping assay market size based on product & service, technology, application, end user, and region.MarketsandMarkets forecasts the Genotyping Assay market to grow from USD 11.8 billion in 2018 to USD 31.9 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 22.0% during the forecast period.Market Dynamics1.
Low Prices of Reprocessed Medical Devices2.
Pressure to Reduce Volume of Regulated Medical WasteThe sequencing segment is expected to witness a faster growth rate in this market due to factors such as, the increasing application areas of DNA sequencing technologies, technological advancements, the availability of high-speed sequencing instruments, and the growing uptake of the hybrid approach of sequencing.Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595The pharmaceutical and biopharmaceutical companies segment is expected to witness the highest growth during the forecast period.
The report analyzes the market by product & service, type of medical device, application, and region.
On the basis of product & service, the reprocessing support and services segment accounted for the largest share in 2016, owing to the increased adoption of third-party reprocessing services over in-house reprocessing services by hospitals, clinics, surgical centers, clinical pathologies, and other healthcare organizations.The major factors that are expected to be driving the genotyping assay market are technological advancements and the decreasing prices of DNA sequencing.
The increasing incidence of genetic diseases and rising awareness of personalized medicine, growing importance of genotyping in drug development, and the increasing demand for bioinformatics solutions in data analysis are also expected to promote market growth in the coming years.
The objective of the report is to define, describe, and forecast the genotyping assay market size based on product & service, technology, application, end user, and region.MarketsandMarkets forecasts the Genotyping Assay market to grow from USD 11.8 billion in 2018 to USD 31.9 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 22.0% during the forecast period.Market Dynamics1.
Low Prices of Reprocessed Medical Devices2.
Pressure to Reduce Volume of Regulated Medical WasteThe sequencing segment is expected to witness a faster growth rate in this market due to factors such as, the increasing application areas of DNA sequencing technologies, technological advancements, the availability of high-speed sequencing instruments, and the growing uptake of the hybrid approach of sequencing.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595The pharmaceutical and biopharmaceutical companies segment is expected to witness the highest growth during the forecast period.
According to the latest research report published by Dhirtek Business Research, the global clinical microbiology market report provides detailed information on the factors driving the growth of the clinical microbiology market.
This pandemic is having an impact on various sectors of the economy.
It predicts that the global economy will suffer as a result of the loss of trillions of dollars.
To compete in a competitive market, the companies must identify product opportunities based on their strengths.
This study provides a platform for understanding the various exciting and rising prospects in the field of clinical microbiology, and it will help every producer, distributor, or even user understand and succeed in this burgeoning industry.
Obtain a Sample Report and the Table of Content for the Clinical Microbiology Market Report:https://www.dhirtekbusinessresearch.com/market-report/Clinical-Microbiology-Market/request-for-sample-report Study Goals and Objectives of Global Clinical Microbiology Market The report provides information on the market impact of clinical microbiology.
The report "Reaction Monitoring Market by Technology (Spectroscopy (MS, IR, UV, NMR, Raman), Chromatography (GC, LC), Calorimetry, Titrimetry, XRD), Mode (Quantitative, Qualitative), End User (Research, Pharma-Biotech, Food & Beverages Co) - Global Forecasts to 2022", The global reaction monitoring market is projected to reach USD 1.52 Billion by 2022 from USD 1.15 Billion in 2017, at a CAGR of 5.7%.Factors such as stringent regulatory guidelines in the pharmaceutical & biotechnology industry; expansion of the food and beverages industry; and Increasing public-private investments in life science research are driving the reaction monitoring market.However, high product costs associated with analytical instruments is the major factor restraining the market growth to a certain extent.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52531136Based on technology, the spectroscopy segment is estimated to account for the largest segment of the market in 2017On the basis of technology, the multiple reaction monitoring market is segmented into spectroscopy, chromatography, X-ray diffraction, calorimetry, and titrimetry.
The spectroscopy segment is expected to account for largest share of the reaction monitoing market in 2017.
The large share of this segment can be attributed to the widespread use of spectroscopic techniques, increasing drug development pipelines, and stringent regulatory compliance for drug manufacturing & food processing protocols.Based on end user, the pharmaceutical, biopharmaceutical, and biotechnology companies segment expected to account for the largest share of the MRM 0market in 2017 Based on end user, the reaction monitoring market is segmented into pharmaceutical, biopharmaceutical, and biotechnology companies, life science and genomic research facilities, food and beverage industry, pollution monitoring and control industry, and other end users.
The pharmaceutical, biopharmaceutical, and biotechnology companies segment is estimated to command the largest share of the global multiple reaction monitoring market in 2017.In 2017, North America is expected to account for the largest share of the reaction monitoring technology market Geographically, the reaction monitoring technology market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America is expected to account for the largest share of the global reaction monitoring market in 2017.
The growth of this region is attributed to the availability of private-public funding & investments for life science research, stringent regulatory framework for drug development & commercialization, effective implementation & industrial compliance with food safety regulations, rising adoption of technologically advanced pollution monitoring & control products, and growing number of clinical researches in this region.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=52531136Key PlayersAgilent (US), Danaher (US), PerkinElmer (US), Shimadzu (Japan), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Bruker (US), Waters (US), Hitachi High-Technologies (Japan), Merck (Germany), ABB (Switzerland), Mettler-Toledo International (US) , and HORIBA (Japan).